Patent · US Active

One dose vaccination against Mycoplasma infections of pigs

US8852613B2 · kind B2 · utility

24Cited by

5References

5Claims

0Family size

Assignee

BOEHRINGER INGELHEIM VETMEDICA GMBH · DE

Inventors

William Charles Ohnesorge · Columbia, US
Isabelle Freiin Von Richthofen · Ciputat, ID
Marika Christine Genzow · Wiesbaden, DE
Martina von Freyburg · Mainz, DE
Carola Kissel · Wiesbaden, DE
Luc-Etienne Fabry · Ingelheim am Rhein, DE
Knut Elbers · Mittelbiberach, DE
Kathleen Kwan Young Park · Warrenton, US

Key dates

Filing date	Apr 24, 2013
Grant date	Oct 7, 2014
Priority date	—
Expiry date	Apr 24, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/35
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a one phase, aqueous vaccine composition for immunizing an animal against infection by Mycoplasma hyopneumoniae, comprising: an immunizing amount of a Mycoplasma hyopneumoniae bacterin, an acrylic acid polymer in the concentration range between 0.8 and 1.2 mg/ml, and a pharmaceutically acceptable carrier, and substantially no oil. It is especially useful for immunizing a pig against infection by Mycoplasma hyopneumoniae for at least 20 weeks after a single administration, which effective immunity is reached within 4 weeks after vaccination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.